HEALTHCARE · MEDICAL DEVICES Boston Scientific Corporation BSX NYSE · $153.2B Q2 FY2026 2 Aug 2026 REV. GROWTH +21.5% OP. MARGIN 22.4% MOAT / STAGE WIDE MOAT ★ ★ ★ ★ ★ ● STAGE 2 ADVANCING Read Analysis ➔ HEALTHCARE · MEDICAL DEVICES Boston Scientific Corporation BSX NYSE · $153.2B Q2 FY2026 2 August 2026 REV. GROWTH +21.5% OP. MARGIN 22.4% MOAT / STAGE WIDE MOAT ● ACCUMULATE Read Analysis ➔